Renal Cell Carcinoma as a Metabolic Disease: An Update on Main Pathways, Potential Biomarkers, and Therapeutic TargetsNicola Antonio di Meo, Giuseppe Lucarelli, Matteo Ferro et al.|International Journal of Molecular Sciences|2022Cited by 190
Immune Checkpoint Inhibitors in Renal Cell Carcinoma: Molecular Basis and Rationale for Their Use in Clinical PracticeFrancesco Lasorsa, Giuseppe Lucarelli, Matteo Ferro et al.|Biomedicines|2023Cited by 161
Metabolomic Approaches for Detection and Identification of Biomarkers and Altered Pathways in Bladder CancerNicola Antonio di Meo, Giuseppe Lucarelli, Matteo Ferro et al.|International Journal of Molecular Sciences|2022Cited by 61
Novel Insights into Autophagy and Prostate Cancer: A Comprehensive ReviewDavide Loizzo, Giuseppe Lucarelli, Marco Spilotros et al.|International Journal of Molecular Sciences|2022Cited by 59